Search results
Dr. Frank Litvack is a Board Certified Internist and Cardiologist and is Chairman of the Board at Credence MedSystems. He began his career in Academic Medicine and was formerly Co-Director of the Cardiovascular Intervention Center at Cedars Sinai in Los Angeles and Professor of Medicine at UCLA.
Dr. Litvack has founded and operated several healthcare ventures, both as chairman and/or chief executive officer, including Progressive Angioplasty Systems Inc., a medical device company that was acquired by United States Surgical Corp. in 1998; Savacor, Inc., a medical device
Dr. Litvack joined the Capricor, Inc. board in 2012 and since November 2013 has been serving as the Company’s Executive Chairman. Dr. Litvack is a native of Canada.
Dr. Litvack received his MD from McGill University and was trained in Cardiology at Cedars-Sinai where he remained as Co-Director of the Cardiovascular Intervention Center for 15 years.
Feb 3, 2016 · Dr. Litvack is a Co-Founder and General Partner in Pura Vida Investments LLC, a health care focused Hedge Fund. In addition he sits on the Boards of several early stage health care companies.
Frank Litvak, MD has been a director of the Company since March 2012. Dr. Litvack served as Chairman (from 2002) and CEO (from 2003) of Conor MedSystems, Inc., a publicly-held company focused on the development of vascular drug delivery systems, until its acquisition by Johnson & Johnson in February 2007. From 2000 to 2005, Dr. Litvack was
Co- Founder and Chairman of Progressive Angioplasty Systems Inc., the developer of the balloon delivery system for the U.S. launch of the Johnson & Johnson Palmaz Schatz stent and other medical products. This company was sold to United States Surgical Corporation in 1998.
